• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组凝血因子VIIa:用于产后致命性出血——印度经验病例系列及文献综述

Recombinant factor VIIa: use in fatal post partum hemorrhage - Indian experience case series and review of literature.

作者信息

Singi Shailesh R, Fernandez Evita, Pandya Sunil T, Badrinath H R

机构信息

CARE Hospitals, Banjara Hills, Hyderabad, 500 082 AP India.

出版信息

Indian J Hematol Blood Transfus. 2009 Mar;25(1):1-5. doi: 10.1007/s12288-009-0001-y. Epub 2009 Apr 6.

DOI:10.1007/s12288-009-0001-y
PMID:23100963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3453477/
Abstract

Postpartum hemorrhage is leading cause of maternal mortality and still remains a challenging condition to treat and hysterectomy may be required to control the bleeding once medical interventions fail. These strategies are not always successful and a direct approach in activating the coagulation system can be more effective and life saving. We describe here the mechanism of action of rFVIIa, review of literature and its use in 10 cases with different causes for PPH with good response.

摘要

产后出血是孕产妇死亡的主要原因,并且仍然是一种难以治疗的情况,一旦医学干预失败,可能需要进行子宫切除术来控制出血。这些策略并不总是成功的,直接激活凝血系统的方法可能更有效且能挽救生命。我们在此描述重组活化凝血因子VII(rFVIIa)的作用机制、文献综述及其在10例不同原因产后出血且反应良好的病例中的应用。

相似文献

1
Recombinant factor VIIa: use in fatal post partum hemorrhage - Indian experience case series and review of literature.重组凝血因子VIIa:用于产后致命性出血——印度经验病例系列及文献综述
Indian J Hematol Blood Transfus. 2009 Mar;25(1):1-5. doi: 10.1007/s12288-009-0001-y. Epub 2009 Apr 6.
2
Recombinant Factor VIIa in Post-partum Hemorrhage: A New Weapon in Obstetrician's Armamentarium.重组凝血因子VIIa用于产后出血:产科医生武器库中的新武器。
N Am J Med Sci. 2012 Apr;4(4):157-62. doi: 10.4103/1947-2714.94938.
3
Recombinant factor VIIa for life-threatening post-partum haemorrhage.重组凝血因子VIIa用于治疗危及生命的产后出血。
Br J Anaesth. 2005 May;94(5):592-5. doi: 10.1093/bja/aei094. Epub 2005 Feb 11.
4
Recombinant activated factor VII in post partum haemorrhage.重组活化凝血因子VII用于产后出血
Niger Med J. 2013 Sep;54(5):289-94. doi: 10.4103/0300-1652.122328.
5
Failure of recombinant factor VIIa to correct the coagulopathy in a case of severe postpartum hemorrhage.重组凝血因子VIIa未能纠正一例严重产后出血患者的凝血障碍。
Transfusion. 2009 Apr;49(4):689-95. doi: 10.1111/j.1537-2995.2008.02029.x.
6
The use of recombinant activated FVII in postpartum hemorrhage.重组活化凝血因子VII在产后出血中的应用。
Clin Obstet Gynecol. 2010 Mar;53(1):219-27. doi: 10.1097/GRF.0b013e3181cc4378.
7
Experience with recombinant activated factor VII for severe post-partum hemorrhage in Japan, investigated by Perinatology Committee, Japan Society of Obstetrics and Gynecology.日本妇产科学会围产医学委员会对重组活化凝血因子VII用于日本严重产后出血的经验进行了调查。
J Obstet Gynaecol Res. 2015 Aug;41(8):1161-8. doi: 10.1111/jog.12712. Epub 2015 May 25.
8
Use of recombinant activated factor VII in massive postpartum haemorrhage.重组活化凝血因子 VII 在产后大出血中的应用。
Eur J Obstet Gynecol Reprod Biol. 2008 Apr;137(2):172-7. doi: 10.1016/j.ejogrb.2007.06.022. Epub 2007 Oct 24.
9
Recombinant human factor VIIa prevents hysterectomy in severe postpartum hemorrhage: single center study.重组人凝血因子 VIIa 预防严重产后出血中的子宫切除术:单中心研究。
J Perinat Med. 2011 Oct 24;40(1):43-9. doi: 10.1515/JPM.2011.109.
10
Use of recombinant factor VIIa to treat life-threatening non-surgical bleeding in a post-partum patient.
Br J Anaesth. 2004 Aug;93(2):298-300. doi: 10.1093/bja/aeh196. Epub 2004 Jun 11.

引用本文的文献

1
Blood transfusion practice in obstetric and gynecology: impact of educational programs to create awareness for judicious use of blood components.妇产科输血实践:教育项目对提高合理使用血液成分意识的影响。
Indian J Hematol Blood Transfus. 2014 Sep;30(3):175-9. doi: 10.1007/s12288-013-0229-4. Epub 2013 Jan 24.
2
Rational Use of Recombinant Factor VIIa in Clinical Practice.重组凝血因子VIIa在临床实践中的合理应用
Indian J Hematol Blood Transfus. 2014 Jun;30(2):85-90. doi: 10.1007/s12288-013-0240-9. Epub 2013 Feb 23.

本文引用的文献

1
Recombinant factor VIIa: a universal haemostatic agent?重组凝血因子VIIa:一种通用的止血剂?
Ann Card Anaesth. 2006 Jul;9(2):97-9.
2
Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile.重组凝血因子VIIa用于抗凝治疗、肝硬化或严重创伤性损伤继发凝血病患者:安全性概况综述
Transfusion. 2006 Jun;46(6):919-33. doi: 10.1111/j.1537-2995.2006.00824.x.
3
Successful treatment of life-threatening bleeding after cesarean section with recombinant activated factor VII.
Clin Appl Thromb Hemost. 2006 Apr;12(2):227-9. doi: 10.1177/107602960601200213.
4
Mechanism of action of factor VIIa in the treatment of coagulopathies.凝血因子VIIa治疗凝血病的作用机制。
Semin Thromb Hemost. 2006 Apr;32 Suppl 1:77-85. doi: 10.1055/s-2006-939557.
5
Use of recombinant factor VIIa for massive postpartum haemhorrage: case series and review of literature.重组凝血因子VIIa用于产后大出血:病例系列及文献综述
J Pak Med Assoc. 2005 Nov;55(11):512-5.
6
Recombinant factor VIIa for life-threatening post-partum haemorrhage.重组凝血因子VIIa用于治疗危及生命的产后出血。
Br J Anaesth. 2005 Oct;95(4):558; author reply 558. doi: 10.1093/bja/aei594.
7
Recombinant factor VIIa for life-threatening post-partum haemorrhage.重组凝血因子VIIa用于治疗危及生命的产后出血。
Br J Anaesth. 2005 May;94(5):592-5. doi: 10.1093/bja/aei094. Epub 2005 Feb 11.
8
The use of recombinant factor VIIa in the treatment of bleeding disorders.重组凝血因子VIIa在出血性疾病治疗中的应用。
Blood. 2004 Dec 15;104(13):3858-64. doi: 10.1182/blood-2004-06-2223. Epub 2004 Aug 24.
9
Use of recombinant factor VIIa to treat life-threatening non-surgical bleeding in a post-partum patient.
Br J Anaesth. 2004 Aug;93(2):298-300. doi: 10.1093/bja/aeh196. Epub 2004 Jun 11.
10
Successful treatment of life-threatening postpartum hemorrhage with recombinant activated factor VII.重组活化凝血因子 VII 成功治疗危及生命的产后出血
Obstet Gynecol. 2003 Jun;101(6):1174-6. doi: 10.1016/s0029-7844(03)00350-8.